17May 2021
Henagliflozin as add‐on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicenter, randomized, double‐blind, placebo‐controlled, phase 3 trial

Henagliflozin as add‐on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicenter, randomized, double‐blind, placebo‐controlled, phase 3 trial

This study evaluated the efficacy and safety of henagliflozin in patients with Type 2 diabetes mellitus (T2DM) inadequately controlled with metformin...

  • #endo-diabetology

Like

Save

Share